Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
N Engl J Med. 2020 Dec 24;383(26):2526-2537. doi: 10.1056/NEJMoa2004444.
N Engl J Med. 2020.
PMID: 33369355
Clinical Trial.
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Saydam G, Ali R, Demir AM, Eskazan AE, Guvenc B, Haznedaroglu IC, Ozcan MA, Salim O, Sonmez M, Tuglular AT, Turgut M, Unal A, Aver B, Bozkurt S, Ozdengulsun B, Ilhan O.
Saydam G, et al. Among authors: tuglular at.
Int J Hematol Oncol. 2022 May 24;11(1):IJH38. doi: 10.2217/ijh-2021-0010. eCollection 2022 Mar.
Int J Hematol Oncol. 2022.
PMID: 35664044
Free PMC article.
Review.
Item in Clipboard
Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia.
Koçkan B, Toptaş T, Atagündüz I, Tuğlular AT, Özer A, Akkiprik M.
Koçkan B, et al. Among authors: tuglular at.
Oncol Lett. 2018 Feb;15(2):2419-2424. doi: 10.3892/ol.2017.7606. Epub 2017 Dec 13.
Oncol Lett. 2018.
PMID: 29434953
Free PMC article.
Item in Clipboard
Cite
Cite